Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.38 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28607657 | 1.00 | LMNA (0.48) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL5855883 | 0.82 | LMNA (0.45) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL5855884 | 0.82 | LMNA (0.45) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL233437 | 0.82 | AOC3 (0.43) | LMNATRPA1TAAR1HTR2AHRH1 | |
| SCHEMBL9921450 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL10012533 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL3534814 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL13452609 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL218804 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 | |
| SCHEMBL3276260 | 0.79 | LMNA (0.46) | LMNAMIFTRPA1HKDC1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191533-B1 | POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF | SIRRUS INC (US) | 2020-11-04 | — | — | EP | claimed |
| EP-1819776-B1 | AESTHETIC, STABLE CHROMATIC EMULSIONS | AVON PROD INC (US) | 2010-03-03 | — | — | EP | claimed |
| US-7276553-B2 | Aesthetic, stable chromatic emulsions | AVON PRODUCTS, INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-20060128883-A1 | Aesthetic, stable chromatic emulsions | AVON PRODUCTS, INC. | 2006-06-15 | — | — | US | claimed |
| EP-0411332-B1 | Antiviral peptides having a 2-oxoalkyl amino acid side chain | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1995-12-06 | — | — | EP | claimed |
| EP-0411332-A1 | Antiviral peptides having a 2-oxoalkyl amino acid side chain | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-02-06 | — | — | EP | claimed |
| CN-112969775-A | Cleaning composition | 诺维信公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-112899086-A | Detergent composition | 诺维信公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-108350400-B | Laundry washing method, use of polypeptides and detergent compositions | 诺维信公司 | 2021-03-30 | — | — | CN | disclosed |
| CN-106164236-B | Detergent composition | 诺维信公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-106164237-B | Detergent composition | 诺维信公司 | 2021-01-05 | — | — | CN | disclosed |
| EP-1819776-B1 | AESTHETIC, STABLE CHROMATIC EMULSIONS | AVON PROD INC (US) | 2010-03-03 | — | — | EP | disclosed |
| US-7276553-B2 | Aesthetic, stable chromatic emulsions | AVON PRODUCTS, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| EP-0411332-B1 | Antiviral peptides having a 2-oxoalkyl amino acid side chain | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1995-12-06 | — | — | EP | disclosed |
| EP-0414200-B1 | Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo [1,5-a]-1,3,5-triazines and a process for production thereof | OTSUKA PHARMA CO LTD (JP) | 1995-08-02 | — | — | EP | disclosed |
| CN-1028528-C | Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo [1,5-a]-1,3,5-triazines | OTSUKA PHARMA CO LTD (JP) | 1995-05-24 | — | — | CN | disclosed |
| US-5137887-A | Xanthine oxidase inhibitors, antipodagric agents | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1992-08-11 | — | — | US | disclosed |
| CN-1049664-A | Optically active 4-hydroxyl-8-(3-low-alkoxy-4-phenyl sulfinyl phenyl) pyrazolo [1,5-α]-1,3,5-triazines salt and method for making thereof | OTSUKA PHARMA CO LTD (JP) | 1991-03-06 | — | — | CN | disclosed |
| EP-0414200-A2 | Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo [1,5-a]-1,3,5-triazines and a process for production thereof | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1991-02-27 | — | — | EP | disclosed |
| EP-0411332-A1 | Antiviral peptides having a 2-oxoalkyl amino acid side chain | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-02-06 | — | — | EP | disclosed |